CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

Quotient Sciences Advances AI-Designed Drug Product into Clinical Development

Phase 1Positive
AI Analysis

Summary

Quotient Sciences has initiated a Phase 1 clinical study of an AI-designed oral drug formulation, marking advancement of the compound into human testing.

Clinical Trial Data

Phase

1

Importance:5/10
Sentiment:
0.60
Phase 1AI-designedoral formulationclinical trial initiation

Read the original article

Published by PR Newswire Clinical Trials on May 28, 2026 1:10 PM

Read Original